Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 11-Mar-24 5:19 PM View:  | Drachman Jonathan G Director | Harpoon Therapeutics, Inc. (HARP) | 11-Mar-24 | Disposition | 5,415 | -- | -- | (100%) 5.42K to 0 | |
| 11-Mar-24 5:28 PM View: | New Leaf Biopharma Opportun... Director 10% Owner | Harpoon Therapeutics, Inc. (HARP) | 11-Mar-24 | Disposition | 10,000 | -- | -- | (100%) 10.0K to 0 | |
| 11-Mar-24 5:16 PM View: | Bailes Joseph S Director | Harpoon Therapeutics, Inc. (HARP) | 11-Mar-24 | Disposition | 5,000 | -- | -- | (100%) 5.0K to 0 | |
| 11-Mar-24 5:17 PM View: | Eastland Julia Marie President and CEO Director | Harpoon Therapeutics, Inc. (HARP) | 11-Mar-24 | Grant | 31,250 | -- | -- | 13% 238.13K to 269.38K | |
| 11-Mar-24 5:26 PM View: | Silvernail Lauren P Director | Harpoon Therapeutics, Inc. (HARP) | 11-Mar-24 | Disposition | 5,000 | -- | -- | (100%) 5.0K to 0 | |
| 11-Mar-24 5:17 PM View: | Lanza Frank J Principal Fin. & Acctng Ofc. | Harpoon Therapeutics, Inc. (HARP) | 11-Mar-24 | Disposition | 18,734 | -- | -- | (100%) 18.73K to 0 | |
| 11-Mar-24 5:25 PM View: | Walker Luke Nathaniel Chief Medical Officer | Harpoon Therapeutics, Inc. (HARP) | 11-Mar-24 | Disposition | 135,000 | -- | -- | (100%) 135.0K to 0 | |
| 11-Mar-24 5:28 PM View: | New Leaf Biopharma Opportun... Director 10% Owner | Harpoon Therapeutics, Inc. (HARP) | 11-Mar-24 | Disposition | 1,463,390 | -- | -- | (78%) 1.87M to 405.78K | |
| 11-Mar-24 5:26 PM View: | Hunt Ronald Director 10% Owner | Harpoon Therapeutics, Inc. (HARP) | 11-Mar-24 | Disposition | 13,224 | -- | -- | (< 1%) 1.88M to 1.87M | |
| 11-Mar-24 5:18 PM View: | Robbins Andrews R Director | Harpoon Therapeutics, Inc. (HARP) | 11-Mar-24 | Disposition | 5,000 | -- | -- | (100%) 5.0K to 0 | |
| 11-Mar-24 5:22 PM View: | Chin Mark Director | Harpoon Therapeutics, Inc. (HARP) | 11-Mar-24 | Disposition | 13,224 | -- | -- | (100%) 13.22K to 0 | |
| 11-Mar-24 5:17 PM View: | Eastland Julia Marie President and CEO Director | Harpoon Therapeutics, Inc. (HARP) | 11-Mar-24 | Disposition | 269,381 | -- | -- | (100%) 269.38K to 0 | |
| 11-Mar-24 5:24 PM View: | Myers Scott Dunseth Director | Harpoon Therapeutics, Inc. (HARP) | 11-Mar-24 | Disposition | 22,665 | -- | -- | (100%) 22.66K to 0 | |
| 11-Mar-24 5:28 PM View: | New Leaf Biopharma Opportun... Director 10% Owner | Harpoon Therapeutics, Inc. (HARP) | 11-Mar-24 | Disposition | 395,783 | -- | -- | (98%) 405.78K to 10.0K | |
| 11-Mar-24 5:26 PM View: | Hunt Ronald Director 10% Owner | Harpoon Therapeutics, Inc. (HARP) | 11-Mar-24 | Disposition | 1,869,170 | -- | -- | (100%) 1.87M to 0 | |
| 11-Mar-24 5:26 PM View: | Hunt Ronald Director 10% Owner | Harpoon Therapeutics, Inc. (HARP) | 08-Mar-24 | Grant | 424 | -- | -- | < 1% 1.88M to 1.88M | |
| 11-Mar-24 5:22 PM View: | Chin Mark Director | Harpoon Therapeutics, Inc. (HARP) | 08-Mar-24 | Grant | 424 | -- | -- | 3% 12.8K to 13.22K | |
| 11-Mar-24 5:19 PM View: | Drachman Jonathan G Director | Harpoon Therapeutics, Inc. (HARP) | 08-Mar-24 | Grant | 415 | -- | -- | 8% 5.0K to 5.42K | |
| 09-Jan-24 4:30 PM View: | Eastland Julia Marie President and CEO Director | Harpoon Therapeutics, Inc. (HARP) | 07-Jan-24 | Grant | 178,500 | -- | -- | 334% 53.5K to 232.0K | |
| 09-Jan-24 4:30 PM View: | Lanza Frank J Principal Fin. & Acctng Ofc. | Harpoon Therapeutics, Inc. (HARP) | 07-Jan-24 | Grant | 15,000 | -- | -- | 446% 3.36K to 18.36K | |
| 09-Jan-24 4:30 PM View: | Walker Luke Nathaniel Chief Medical Officer | Harpoon Therapeutics, Inc. (HARP) | 07-Jan-24 | Grant | 115,000 | -- | -- | 575% 20.0K to 135.0K | |
| 03-Jan-24 4:30 PM View: | Myers Scott Dunseth Director | Harpoon Therapeutics, Inc. (HARP) | 01-Jan-24 | Grant | 2,048 | -- | -- | 10% 20.62K to 22.67K | |
| 03-Jan-24 4:30 PM View: | Hunt Ronald Director 10% Owner | Harpoon Therapeutics, Inc. (HARP) | 01-Jan-24 | Grant | 1,072 | -- | -- | < 1% 1.88M to 1.88M | |
| 03-Jan-24 4:30 PM View: | Chin Mark Director | Harpoon Therapeutics, Inc. (HARP) | 01-Jan-24 | Grant | 1,072 | -- | -- | 9% 11.73K to 12.8K | |
| 28-Nov-23 4:29 PM View: | Silvernail Lauren P Director | Harpoon Therapeutics, Inc. (HARP) | 27-Nov-23 | Grant | 5,000 | -- | -- | 100% 0 to 5.0K | |
| 28-Nov-23 4:26 PM View: | Myers Scott Dunseth Director | Harpoon Therapeutics, Inc. (HARP) | 27-Nov-23 | Grant | 5,000 | -- | -- | 32% 15.62K to 20.62K | |
| 28-Nov-23 4:28 PM View: | Robbins Andrews R Director | Harpoon Therapeutics, Inc. (HARP) | 27-Nov-23 | Grant | 5,000 | -- | -- | 100% 0 to 5.0K | |
| 28-Nov-23 4:25 PM View: | Drachman Jonathan G Director | Harpoon Therapeutics, Inc. (HARP) | 27-Nov-23 | Grant | 5,000 | -- | -- | 100% 0 to 5.0K | |
| 28-Nov-23 4:25 PM View: | Hunt Ronald Director 10% Owner | Harpoon Therapeutics, Inc. (HARP) | 27-Nov-23 | Grant | 5,000 | -- | -- | < 1% 1.88M to 1.88M | |
| 28-Nov-23 4:23 PM View: | Chin Mark Director | Harpoon Therapeutics, Inc. (HARP) | 27-Nov-23 | Grant | 5,000 | -- | -- | 74% 6.73K to 11.73K | |
| 28-Nov-23 4:22 PM View: | Bailes Joseph S Director | Harpoon Therapeutics, Inc. (HARP) | 27-Nov-23 | Grant | 5,000 | -- | -- | 100% 0 to 5.0K | |
| 28-Nov-23 4:30 PM View: | Eastland Julia Marie President and CEO Director | Harpoon Therapeutics, Inc. (HARP) | 26-Nov-23 | Grant | 50,000 | -- | -- | 1427% 3.5K to 53.5K | |
| 28-Nov-23 4:31 PM View: | Lanza Frank J Principal Fin. & Acctng Ofc. | Harpoon Therapeutics, Inc. (HARP) | 26-Nov-23 | Grant | 2,000 | -- | -- | 147% 1.36K to 3.36K | |
| 28-Nov-23 4:32 PM View: | Walker Luke Nathaniel Chief Medical Officer | Harpoon Therapeutics, Inc. (HARP) | 26-Nov-23 | Grant | 20,000 | -- | -- | 100% 0 to 20.0K | |
| 27-Oct-23 4:41 PM View: | New Leaf Biopharma Opportun... 10% Owner | Harpoon Therapeutics, Inc. (HARP) | 25-Oct-23 | Purchase | 171,500 | -- | -- | 10% 1.7M to 1.87M | |
| 27-Oct-23 4:03 PM View: | Hunt Ronald Director 10% Owner | Harpoon Therapeutics, Inc. (HARP) | 25-Oct-23 | Purchase | 1,543,500 | -- | -- | 464% 332.4K to 1.88M | |
| 27-Oct-23 4:41 PM View: | New Leaf Biopharma Opportun... 10% Owner | Harpoon Therapeutics, Inc. (HARP) | 25-Oct-23 | Purchase | 1,372,000 | -- | -- | 421% 325.67K to 1.7M | |
| 02-Oct-23 10:00 PM View: | Chin Mark Director | Harpoon Therapeutics, Inc. (HARP) | 01-Oct-23 | Grant | 3,035 | -- | -- | 82% 3.69K to 6.73K | |
| 02-Oct-23 10:00 PM View: | Myers Scott Dunseth Director | Harpoon Therapeutics, Inc. (HARP) | 01-Oct-23 | Grant | 5,797 | -- | -- | 59% 9.82K to 15.62K | |
| 06-Jul-23 6:36 PM View: | Hunt Ronald Director 10% Owner | Harpoon Therapeutics, Inc. (HARP) | 01-Jul-23 | Grant | 18,656 | -- | -- | < 1% 3.18M to 3.2M | |
| 06-Jul-23 6:34 PM View: | Myers Scott Dunseth Director | Harpoon Therapeutics, Inc. (HARP) | 01-Jul-23 | Grant | 35,634 | -- | -- | 57% 62.58K to 98.22K | |
| 06-Jul-23 6:37 PM View: | Chin Mark Director | Harpoon Therapeutics, Inc. (HARP) | 01-Jul-23 | Grant | 18,656 | -- | -- | 102% 18.29K to 36.94K | |
| 04-Apr-23 5:05 PM View: | Hunt Ronald Director 10% Owner | Harpoon Therapeutics, Inc. (HARP) | 01-Apr-23 | Grant | 18,285 | -- | -- | < 1% 3.17M to 3.18M | |
| 04-Apr-23 5:06 PM View: | Myers Scott Dunseth Director | Harpoon Therapeutics, Inc. (HARP) | 01-Apr-23 | Grant | 34,925 | -- | -- | 126% 27.66K to 62.58K | |
| 04-Apr-23 5:03 PM View: | Colowick Alan Director | Harpoon Therapeutics, Inc. (HARP) | 01-Apr-23 | Grant | 16,456 | -- | -- | 100% 0 to 16.46K | |
| 04-Apr-23 5:02 PM View: | Chin Mark Director | Harpoon Therapeutics, Inc. (HARP) | 01-Apr-23 | Grant | 18,285 | -- | -- | 100% 0 to 18.29K | |
| 04-Apr-23 5:07 PM View: | Viney Joanne L. Director | Harpoon Therapeutics, Inc. (HARP) | 01-Apr-23 | Grant | 21,028 | -- | -- | 100% 0 to 21.03K | |
| 27-Mar-23 5:37 PM View: | Hunt Ronald Director 10% Owner | Harpoon Therapeutics, Inc. (HARP) | 23-Mar-23 | Purchase | 10,000 | $1,000.00 | $10,000,000.00 | < 1% 3.16M to 3.17M | |
| 22-Sep-21 10:00 PM View: | Erbez Georgia Chief Financial Officer | Harpoon Therapeutics, Inc. (HARP) | 22-Sep-21 | Market Purchase | 10,300 | $8.10 | $83,430.00 | 12% 87.91K to 98.21K | (2%) |
| 06-Jul-21 6:01 PM View: | Wesche Holger Chief Scientific Officer | Harpoon Therapeutics, Inc. (HARP) | 01-Jul-21 | Market Option Sale (Planned) | 10,000 | $14.00 | $140,000.00 | (16%) 62.85K to 52.85K |
